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1. Introduction
   Systemic lupus erythematosus (SLE) is a chronic inflammatory 
connective tissue disorder that involves joints, kidneys, mucous 
membranes, and blood vessel walls. Although genetic predisposition 
is crucial in the development of SLE, attention has been recently 
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Objective: To investigate the potential role of human cytomegalovirus lower matrix 
phosphoprotein 65 (HCMV-pp65) in murine systemic lupus erythematosus (SLE). 
Methods: The prokaryotic plasmid pET-28b-pp65 was constructed to express the HCMV-
pp65 protein. BXSB mice and C57BL/6 mice were inoculated with pp65 eukaryotic plasmid 
pcDNA3.0-pp65 intramuscularly 5 times at 2-week intervals, and then the blood of the mice 
was subsequently collected via the retro-orbital vein. Indirect ELISAs were used to evaluate 
the concentration of anti-pp65 immunoglobulin G, anti-double-stranded DNA and antinuclear 
antibodies. Interleukin-1β and tumor necrosis factor-α were also determined by competitive 
ELISA. At the same time, 3 major SLE-related circulating microRNAs were examined by 
quantitative RT-PCR. 
Results: The early production of autoantibodies was observed in pp65-immunized male BXSB 
as well as C57BL/6 mice. Overexpression of interleukin-1β and tumor necrosis factor-α were 
detected in pp65-immunized male BXSB mice. Quantitative RT-PCR analyses showed that three 
SLE related microRNAs (microRNA-126, microRNA-125a, and microRNA-146a) were down-
regulated in peripheral blood mononuclear cells of pp65-immunized mice. 
Conclusions: Our findings indicate that HCMV-pp65 immunization strongly triggers the 
development and progression of SLE-like disease in both BXSB and C57BL/6 mice, which 
indicates that the immune responses induced by HCMV-pp65 may be involved in the 
development of SLE.
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focused on the contribution of environmental factors, among 
which infection is essential[1]. The relationship between SLE and 
infection with viruses, bacteria, or parasites, has been well known 
in the literature[2]. Some viruses, such as human cytomegalovirus 
(HCMV)[3], Epstein–Barr virus and parvovirus B19 may play a 
pivotal role in SLE[4,5].
   HCMV is a common DNA virus of the herpes family with a high 
prevalence in human. The potential role of HCMV in the etiology 
of SLE has been extensively studied. Recent reports have shown 
the increasing levels of anti-HCMV immunoglobulin G (IgG) and 
immunoglobulin M antibodies in sera of SLE patients compared 
with healthy controls[6-10]. It has also been suggested that an 
association between the presence of HCMV antibodies and anti-
Smith/ribonucleoprotein was found for patients with SLE but not 
those with mixed connective-tissue disease[11]. Moreover, it was 
reported that in a case, acute HCMV infection may have been 
the precipitating event in the development of SLE[12]. Based on 
these findings of reported cases, a potential role of HCMV in the 
development and/or progression of SLE has been suggested.
   In particular, the lower matrix phosphoprotein 65 (pp65), 
a dominant tegument protein of the HCMV virion, plays a 
significant role in immune evasion, and thereby, in controlling 
the innate and adaptive immune responses via HCMV-specific 
cytotoxic T lymphocytes[13]. Thus, the effect of pp65 is mostly 
attributed to preventing infected cells from being destroyed. 
Several studies have shown that pp65 may be associated with 
various autoimmune responses. These observations highlight 
the fact that immunization of either BALB/c or NZB/W F1 mice 
with one cytomegalovirus-specific peptide results in multiple 
autoreactive antibodies[14,15]. However, it would be of high 
priority to learn whether those autoantibodies also exist isolated 
from individuals with a background predisposed to SLE, 
especially whether more SLE related factors, such as cytokines 
and microRNAs, could be regulated by cytomegalovirus pp65 
affection. 
   To further clarify the possible role of HCMV in SLE, authors 
chose the HCMV-pp65 recombinant plasmid as the vaccine to 
study its effect in C57BL/6 and SLE-prone BXSB mice by detecting 
a series of SLE-related serological makers and microRNAs 
(microRNA-125a, microRNA-126, and microRNA-146a), which 
served as potential biomarkers of SLE. 
2. Materials and methods
2.1. Plasmids
   Prokaryotic expression plasmid pET28b-pp65 encoded the 
full-length HCMV-pp65 (National Center of Biotechnology 
Information reference sequence: NC_006273.2, synthesized by 
Sangon Biotech. Co., Ltd, Shanghai, China). Subsequently, the 
HCMV-pp65 fragment (1 705 bp) was generated by digesting 
pET-28b-pp65 with BamH1/Xho1 and ligated in pcDNA3.0 at the 
same sites using T4 DNA ligase (Takara Bio Inc., Kyoto, Japan). 
Recombinant plasmid, namely pcDNA3.0-pp65, was verified by 
agarose gel electrophoresis and sequencing.
2.2. Immunization of mice 
   Ten male BXSB mice (6 weeks old) were purchased from Jackson 
Laboratory (Bar Harbor, ME, USA), and 14 C57BL/6 mice (6 weeks 
old) were purchased from the Animal Center of the Academy of 
Military Medical Sciences (Beijing, China). In this study, BXSB and 
C57BL/6 mice constituted SLE-prone and healthy control groups, 
respectively. The study was approved by the Ethics Committee of 
Peking Union Medical College. All the BXSB and C57BL/6 mice 
were raised in a specific pathogen free animal facility and were then 
divided randomly into Groups BP (BXSB-pp65, n=5), BC (BXSB-
control, n=5), CP (C57BL/6-pp65, n=7), and CC (C57BL/6-control, 
n=7). Treatment involved five times 100-μL intramuscular injections 
at 2-week intervals, with 100 μg of either pcDNA3.0 plasmids 
encoding HCMV-pp65 (for Groups BP and CP) or with no insert 
(for Groups BC and CC) dissolved in sterile saline. Serum was 
separated after blood collection from the tail vein 1 d prior to each 
immunization. All the mouse were sacrificed 2 weeks after the last 
inoculation. Serum and peripheral blood mononuclear cells (PBMCs) 
of each sample used for the following detection were stored at −80 °C 
within 1 h of collection.
2.3. Prokaryotic expression, purification, and western blot 
analysis of HCMV-pp65 protein
   Plasmid pET28b-pp65, which contains a N-terminal 6His-tag, was 
transformed into Escherichia coli strain BL21 (DE3). Expression 
of HCMV-pp65 proteins was induced at 37 °C in Lysogeny broth 
medium supplemented with 0.8 mmol/L isopropyl 1-thio-β-D-
galactoside for 10 h. After induction, cells were harvested and 
lysed by sonication in lysis buffer (KCl 22.4 g/L, KH2PO4 6.8 g/
L, lysozyme 0.1 mg/mL, phenylmethanesulfonyl fluoride 1 mmol/
L, urea 8 mol/L; pH 8). The expressed N-terminal His-tagged 
pp65 protein (72 kDa) was then purified using Ni-NTA Magnetic 
Beads (Bio-Rad Inc., Hercules, CA, USA) and analyzed by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis on 10% gels. 
Subsequently, the purified HCMV-pp65 protein was refolded at 4 °C 
in urea gradient (from 8 mol/L to 1 mol/L) refolding buffer (Tris-
HCl 50 mmol/L, KCl 100 mmol/L, MgCl2 12.5 mmol/L, ethylene 
diamine tetraacetic acid 1 mmol/L, DL-Dithiothreitol 1 mmol/L, 
glycerin 10%, phenylmethanesulfonyl fluoride 0.1 mmol/L), which 
was changed every 6 h. After evaluating the antigenicity of refolded 
HCMV-pp65 protein by western blot using anti-cytomegalovirus 
pp65 antibody (Abcam Inc., Cambridge, MA, USA), the protein 
concentration was measured with the Bradford assay (Bio-Rad Inc., 
Hercules, CA, USA) using bovine serum albumin as a standard.
2.4. Indirect ELISA for the immunological response, anti-
double stranded DNA (anti-dsDNA) and antinuclear antibodies 
(ANA) 
   To detect the titer of anti-pp65 IgG of immunized mice, 100 
μL/well of 2 μg/mL refolded pp65 protein diluted in 0.05 mol/L 
carbonate buffer (pH 9.6) was coated onto ELISA plates (Corning-
Costar Corp., Corning, NY, USA) at 4 °C overnight. The plates 
were then washed 5 times with phosphate buffered saline (PBS) 
and blocked at 37 °C for 2 h with blocking buffer (1.5% bovine 
serum albumin and 0.05% Tween 20 in PBS). After washing with 
PBS containing 0.05% (w/v) Tween 20, each well was incubated 
with 100 μL of anti-sera (diluted by blocking buffer at 1:200) 
for 1 h at room temperature. Afterwards, each well was washed 
and incubated with anti-mouse IgG, horseradish peroxidase-
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linked secondary antibody. Finally, the absorbance at 450 nm for 
each well was measured after incubating with o-phenylenediamine 
dihydrochloride as a substrate. In addition, anti-dsDNA antibody and 
ANA in serum were measured with precoated ELISA plates (R&D 
Systems, Inc., MN, USA). All tests were performed in duplicate. 
2.5. Indirect immunofluorescence (IIF)
   Two weeks after the last immunization, the serum samples in each 
group was tested by IIF for ANA according to the manufacturer’s 
instruction (Euroimmun, Lübeck, Germany). In summary, sera were 
diluted to 1:100 and applied to commercially available slides coated 
with fixed Hep-2 cells (Euroimmun, Lübeck, Germany) for 30 min 
at room temperature. After washing for 5 min with PBS containing 
0.05% (w/v) Tween 20, fluorescein isothiocyanate-labeled goat 
anti-rabbit IgG (Santa Cruz Biotechnology, Inc., CA, USA) were 
added at 1:100 dilution to each spot and incubated for 30 min. Slides 
were then embedded and visualized by a fluorescence microscope 
(Olympus, Tokyo, Japan). 
2.6. ELISA for cytokines 
   Mouse competitive ELISA kits (Dakewe, Beijing, China) were used 
to measure the concentration of serum cytokines interleukin (IL)-1β 
and tumor necrosis factor (TNF)-α according to the manufacturer’s 
instructions. For each assay, a standard curve was established by 
calibrators supplied with the kits and then used to calculate the 
concentrations of IL-1β or TNF-α. All tests were performed in 
duplicate.
2.7. Extraction of RNA and evaluation of microRNA levels 
   To isolate total RNA from PBMCs, TRIzol® Reagent (Invitrogen, 
Carlsbad, CA, USA) was used according to the manufacturer’s 
protocol. For RT and real-time PCR, the PrimeScript™ RT reagent 
Kit (Takara Bio Inc., Kyoto, Japan) and the SYBR® Premix 
Ex Taq™ II (Takara Bio Inc., Kyoto, Japan) were purchased 
and used according to the manufacturer’s instruction. U6 small 
nuclear RNA was used as an endogenous control. The stem-loop 
RT primers and PCR primer sets specific for each microRNA 
and U6 are shown in Table 1. All reactions were performed in 
triplicate. Differences in the microRNA levels in each sample 
were normalized by U6. The comparative Ct method (2
−ΔCt) was 
used to calculate fold changes of microRNAs expression, where 
ΔCt=(Ct microRNA-Ct U6). To simplify the presentation of the data, the 
relative expression values were multiplied by 100.
2.8. Statistical analysis
   Comparison of categorical variables was performed using Fischer’s 
exact test. The Mann–Whitney U test (GraphPad Prism; GraphPad 
Software Inc., San Diego, CA, USA) was used for comparison of 
continuous data which were expressed as mean±SEM. P<0.05 was 
considered to be statistically significant.
3. Results
3.1. Analysis of HCMV-pp65 production and antigenicity 
   After digestion by BamH1 and Xho1, the purified pcDNA3.0-pp65 
was subjected to 1% agarose gel electrophoresis and a band between 
1 000 bp and 2 000 bp was observed for the sample. Subsequently, 
the pcDNA3.0-pp65 was verified by sequencing. To confirm that 
pp65 was produced in the Escherichia coli strain BL21 expression 
system, a purified sample was analyzed by denaturing sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis. The molecular 
weight of the proteins in the sample was approximately 72 kDa. 
After refolding, the purified protein was then analyzed by western 
blot using anti-cytomegalovirus pp65 antibody (Figure 1). These 
results indicated that the HCMV-pp65 protein was successfully 
expressed and displayed antigenic properties in vitro.  
pp65
wash 
buffer
before 
refolding
after 
refolding
Figure 1. Identification of HCMV-pp65 protein. 
Western blot analysis of purified pp65 protein after refolding. Lane 1: The 
non-specific proteins in wash buffer; Lane 2: pp65 Protein in eluent before 
refolding; Lane 3: pp65 Protein in eluent after refolding. 
Table 1 
Primers for miRNAs quantitative RT-PCR.
ID Primer Sequence
Micro-125a Stem-loop RT primer GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACT CAC AG
Forward primer GGC TCC CTG AGA CCC TTT A
Reverse primer GTG CAG GGT CCG AGG T
Micro-126 Stem-loop RT primer GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACC GCG TA
Forward primer GGC GGC ATT ATT ACT TTT GG
Reverse primer GTG CAG GGT CCG AGG T
Micro-146a Stem-loop RT primer GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACA ACC CA
Forward primer GGC GTG AGA ACT GAA TTC CA
Reverse primer GTG CAG GGT CCG AGG T
U6 RT primer CGC TTC ACG AAT TTG CGT GTC AT
Forward primer GCT TCG GCA GCA CAT ATA CTA AAA T
Reverse primer CGC TTC ACG AAT TTG CGT GTC AT
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3.2. Analysis of anti-pp65 response
   Antibody responses were elicited by immunization with the 
recombinant plasmid pcDNA3.0-pp65 (Groups BP, CP) and blank 
plasmid (Groups BC, CC) were all assessed 2 weeks after each 
immunization. It is showed that 6 weeks after the first incubation, 
anti-pp65 antibody was significantly higher in pcDNA3.0-pp65 
immunized C57BL/6 [0.45 (0.39 to 0.50) vs. 0.28 (0.25 to 0.33), 
P<0.001] and BXSB [0.74 (0.49 to 0.94) vs. 0.29 (0.24 to 0.34), 
P<0.05] mouse than pcDNA3.0 vector immunized C57BL/6 and 
BXSB controls, respectively (Figure 2A). By contrast, the sera of 
blank plasmid groups presented negative reactivity (Figure 2B). 
These results indicated that the pcDNA3.0-pp65 construct, which 
was used to immunize the mice, expressed pp65 protein and induced 
specific antibodies in mice.
Figure 2. Mean levels of IgG against HCMV-pp65 (±SEM) in sera from 
mice (BXSB and C57/BL6). 
A: Anti-pp65 activities of C57BL/6 mice; B: Anti-pp65 activities of 
BXSB mice. Anti-pp65 activities were determined by UV absorbance at 
450 nm. The error bars indicate the SEM. Values in tests are expressed as 
mean±SEM. *: P<0.05; **: P<0.01 (Mann-Whitney U test, compared with 
control).
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3.3. Analysis of autoantibody development
   On performing the ELISA to quantify levels of anti-dsDNA 
antibody and ANA in the sera of mice every 2 weeks after each 
immunization, we found a considerable increase in autoantibodies 
in all pp65-immunized mice. Treatment with pp65 significantly 
increased the levels of ANA [0.67 (0.48 to 0.89) vs. 0.33 (0.30 to 
0.36), P<0.05] and anti-dsDNA antibody [0.50 (0.45 to 0.55) vs. 0.34 
(0.31 to 0.37), P<0.05] in BXSB mice by 8 weeks post inoculation 
(Figures 3B and 3D), and the titers increased in the next 2 weeks. 
Surprisingly, serum of pp65-immuned C57BL/6 mice also showed 
statistically higher levels of ANA [0.13 (0.10 to 0.15) vs. 0.04 (0.03 
to 0.04), P<0.001] and anti-dsDNA antibody [0.13 (0.10 to 0.15) 
vs. 0.04 (0.01 to 0.06), P<0.001] (Figures 3A and 3C), but the titers 
decreased in the next 2 weeks. Notably, the change of autoantibody 
titer in BP group was more dramatic than that in CP group compared 
with respective controls. 
Figure 3. Mean levels of IgG against nuclear components (±SEM) and 
dsDNA (±SEM) in sera of mice (BXSB and C57BL/6) immunized with 
plasmids encoding HCMV-pp65 and vector only. 
A: Antinuclear antibodies activity of C57BL/6 mice; B: Antinuclear 
antibodies activity of BXSB mice; C: Anti-dsDNA activity of C57BL/6 
mice; D: Anti-dsDNA activity of BXSB mice. Activities of antibodies 
were determined by UV absorbance at 450 nm. The error bars indicate the 
SEM. Values in tests are expressed ad mean±SEM. *: P<0.05; **: P<0.01; 
***: P<0.001 (Mann–Whitney U test, compared with vector control).
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   Moreover, 2 weeks after the last immunization, the serum samples 
in each group was tested by IIF and determined to be positive or 
negative for ANA based on known controls. Routinely, intensity of 
IIF was evaluated by titers (threshold value 1:40). Because low titer 
positive ANAs are fairly common in BXSB mice, the threshold titer 
of strongly positive ANAs was defined as 1:160 in our study. As 
summarized in Table 2, the serum of Groups BP and CP showed 
significantly stronger reacting ANA than Groups BC (threshold value 
1:160, P<0.05) and CC (threshold value 1:40, P<0.05), respectively. 
ANA immunofluorescence staining of samples from each group are 
shown in Figure 4. We also found that ANA of these positive samples 
yielded a homogeneous fluorescence staining of the nuclear. 
Table 2 
Detection of ANA by indirect immunofluorescence.
Groups Negative Positive P value
(≤1:40) 
[n (%)]
Weakly 
(1:40<titre≤1:160) [n (%)]
Strongly 
(>1:160) [n (%)]
CC   7 (100.00) 0 (0.00) --- <0.05
CP 2 (28.57)   5 (71.43) ---
BC ---   4 (80.00) 1 (20.0) <0.05
BP ---   1 (20.00) 4 (80.0)
   Taken together, the levels of anti-dsDNA antibody and ANA in 
Group BP were significantly higher than those in the Group BC 
after the fourth incubation. Similarly, the serum in the Group CP 
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Figure 5. The effect of immunization with plasmid encoding HCMV-pp65 and vector with no insert on the content of cytokines (IL-1β and TNF-α) in 
sera and relative expression levels (2−ΔCt×100) of mature microR-146a, miR-125a, and microR-126 in PBMCs from mice (BXSB and C57/BL6) after the 
last injection.
A: The concentration (pg/mL) of IL-1β in each group; B: The concentration (pg/mL) of TNF-α in each group; C: The expression level of miR-
146a (normalized by U6) in each group; D: The expression level of miR-125a (normalized to U6) in each group; E: The expression level of miR-126 
(normalized by U6) in each group. The error bars indicate the SEM. Values in tests are the mean±SEM. **: P<0.01; ***: P<0.001. P values are listed at the 
top (Mann–Whitney U test, compared with vector control).
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Figure 4. ANA immunofluorescence staining in sera from mouse (BXSB and C57/BL6) immunized with plasmid encoding HCMV-pp65 and vector only. 
The staining patterns shown are representative for each group. Sera were incubated with Hep-2 cells at a dilution of 1:100. ANA were detected with 
fluorescein isothiocyanate-labeled goat anti-rabbit IgG secondary antibody. Magnification was ×20.
    CC                                                              CP                                                           BC                                                          BP
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had higher levels of the 2 autoantibodies than the CC group did after 
the same time of immunization. These findings showed that the 
humoral autoantibody response could be induced by pcDNA-3.0-
pp65 plasmid in both C57BL/6 and BXSB mice.
3.4. Analysis of cytokine secretion
   All the sera were diluted in 1:2 and analyzed by competitive 
ELISA. IL-1β and TNF-α were negative in C57BL/6 mice (Group 
CC), and were not significantly increased in pp65-treated C57BL/6 
mice (Group CP). However, IL-1β was detectable in 80% of Group 
BC mice and 100% of Group BP mice (Figure 5A). The expression 
of IL-1β in Group BP mice reached statistical significance 
compared with Group BC controls [76.50 (64.66 to 92.53) vs. 
19.70 (18.83 to 21.46), P<0.05]. In addition, sera of all the Group 
BP and Group BC mice produced TNF-α. As shown in Figure 5B, 
mice treated with pcDNA3.0-pp65 had a significantly higher TNF-α 
level than those treated with vehicle [127.50 (101.15 to 154.30) 
vs. 35.95 (35.11 to 36.73), P<0.05]. Thus, these data indicated 
that BXSB mice stimulated by pp65 had higher IL-1β and TNF-α 
production.
3.5. Analysis of differential microRNA expression 
   BXSB mice had significantly lower levels of microRNA-146a, 
microRNA-125a, and microRNA-126 compared with C57BL/6 
mice (0.50-fold, 0.47-fold, and 0.18-fold; P<0.01, 0.01, and 
0.01, respectively). Moreover, the expression of microRNA-
146a, microRNA-125a, and microRNA-126 were also markedly 
decreased in PBMC from the Group BP compared with the Group 
BC (0.46-fold, 0.52-fold, and 0.17-fold, P<0.01, 0.01, and 0.01, 
respectively). The down-regulation of microR-146a, microR-125a, 
and microR-126 were also observed in PBMC from the Group CP 
compared with the Group CC (0.48-fold, 0.53-fold, and 0.38-fold; 
P<0.001, 0.001, and 0.01, respectively). In summary, quantitative 
RT-PCR analysis clearly indicated that the expression of microR-
125a, microR-126, and microR-146a was significantly down-
regulated in PBMC from pp65-immunized BXSB and C57BL/6 
mice compared with control BXSB and C57BL/6 mice, respectively 
(Figures 5C, 5D, and 5E).
4. Discussion 
   This study was performed to investigate the association between 
HCMV-pp65 immunization and the development of SLE in mice. 
In the present study, by detecting antibodies, cytokines, and 
microRNAs related with SLE, we verified that HCMV-pp65 could 
contribute to both initiation and exacerbation of SLE in non 
autoimmune-prone C57BL/6 mice and lupus-prone BXSB mice, 
respectively. 
   The spontaneous lupus-like syndrome was advanced in BXSB 
males, which are the offspring of a cross between C57BL/6 
females and SB/Le males. The Y chromosome of BXSB mice is 
derived ultimately from the strain SB/Le. Thus, we selected BXSB 
and C57BL/6 mice as SLE-prone and healthy control groups, 
respectively. 
   The results presented above indicated that the immunization 
of pcDNA3.0-pp65 induced humoral activity to the pp65 antigen 
in both BXSB and C57BL/6 mice. After 5 times of infection by 
pp65, the fluorescence intensities of ANA staining in serum 
of BP and CP groups were significantly higher than BC and 
CC groups, respectively. The positive samples which yielded a 
homogenous pattern of ANA staining-interphase cells showed 
homogeneous nuclear staining while mitotic cells showed staining 
of the condensed chromosome regions. Therefore, we knew that 
if pp65 could induce the higher level of not only ANA, but also 
the anti-dsDNA antibody. Subsequently, we tested both antibodies 
after each immunization and found that pcDNA3.0-pp65 could 
induce the significant increase of ANA and anti-dsDNA antibody 
production in both strains of mice by 8 weeks postinfection. 
Anti-dsDNA antibody is a very specific marker for SLE. Similar 
to these results in BXSB mice, a recent study found that pp65 
increased the levels of ANA and anti-dsDNA antibody in another 
strain of SLE-prone mice (NZB/WFI), and the titers increased 
persistently[14]. Accordingly, pp65 immunization is likely to trigger 
the autoimmune responses and increase the level of anti-dsDNA 
antibodies highly associated with SLE in mice with or without a 
background predisposed to SLE. 
   Additionally, some results have aroused our interest. Firstly, 
the anti-pp65 antibody level was found to be lower in pp65-
immunized C57BL/6 mice than in pp65-immunized BXSB mice. 
Moreover, the autoimmune responses induced by pp65 vaccine 
were more powerful in BXSB mice than in C57BL/6 mice. One 
possible explanation is that the cytotoxic T lymphocytes responses 
initiated by pcDNA3.0-pp65 vaccine could restrain the humoral 
responses in normal individuals[16], whereas an imbalance of 
T-helper 1/T-helper 2 in autoimmune patients makes the T-helper 
2-mediated humoral responses greater[17]. Lastly, the titers of these 
autoantibodies increased in BXSB-pp65 mice while decreasing in 
C57BL/6-pp65 mice in the last 2 weeks of immunization. However, 
it was reported that pp65 could increase the levels of anti-dsDNA 
antibody continuously in C57BL/6 mice[14], which was not the 
same as results of ours. Thus, further studies are needed to explain 
this discrepancy. 
   To further analyze the possible link between pp65 vaccine and 
SLE, 3 well-studied microRNAs (microR-125a, microR-126, and 
microR-146a) closely related to SLE were chosen and examined by 
quantitive RT-PCR. We noted that the expression of microR-125a, 
microR-126, and microR-146a in PBMCs were all down-regulated 
significantly more in BXSB mice than in C57BL/6 mice. Similarly, 
several groups of investigators have shown that microR-146a and 
microR-125a were down-regulated in PBMCs of SLE patients[18,19]. 
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Nevertheless, another recent report showed that the microR-126 
level was much higher in SLE patients than in controls[20]. To the 
best of our knowledge, various disease stages, treatment histories, 
samples types, or detection methods are possible causes for the 
discrepancy in data reported by different studies, though the most 
important difference is likely in the genetic backgrounds of diverse 
species. Thus, to a certain extent, the down-regulated expressions 
of microR-125a, microR-126, and microR-146a, which served as 
potential biomarkers of SLE, may accompany the onset of SLE in 
mice. Furthermore, our findings revealed that immunization of 
pcDNA3.0-pp65 sharply decreased expressions of microR-125a, 
microR-126, and microR-146a in the PBMCs of both BXSB and 
C57BL/6 mice. Hence, we deduced that immunization with pp65 
extends the progress of SLE in mice at the level of microRNA, 
though the precise roles of these down-regulated microRNAs still 
need to be identified in future researches. 
   We also observed that levels of TNF-α and IL-1β were higher 
in SLE-prone BXSB than in normal C57BL/6 mice. The observed 
discrepancy between C57BL/6 and BXSB mice could be explained 
by the mechanism that anti-dsDNA antibody induced the secretion 
of IL-1β and TNF-α[21,22]. Although pp65 immunization was 
able to induce ANA and anti-dsDNA antibody production even 
in the normal C57BL/6 mice, the secretion levels of TNF-α and 
IL-1β in C57BL/6 mice stimulated by pp65 were maintained. 
On the contrary, after immunization with pp65-DNA vaccine, 
the secretion levels of TNF-α and IL-1β in BXSB mice increased 
dramatically. In particular, IL-1β and TNF-α were not only verified 
as negative regulators of microR-146a, but were also suppressed 
by microR-146a expression[23,24]. microR-125a was also found 
to decrease the secretion of TNF-α[25]. From these results in 
C57BL/6 mice, it is speculated that the immunized effects of pp65 
in SLE-prone mice go stronger and faster than in healthy mice, 
and immunization with pp65 may cause responses earlier at the 
microRNA level rather than at the cytokine level. Accordingly, 
the slight down-regulations of these microRNAs in C57BL/6 mice 
are not enough to influence the secretion of cytokines. Another 
explanation may be the repression of TNF-α and IL-1β secretion 
by pp65 vaccine in normal individuals. Taken together, we 
suggest that pp65 may have negatively regulated microR-125a and 
microR-146a expression, and subsequently increased the TNF-α 
and IL-1β secretion in BXSB mice. Although the relationship of 
HCMV-pp65 and SLE-related autoantibodies, cytokines, as well 
as miRcroNAs have been investigated in the present research, the 
precise mechanism still needs to be determined. Therefore, it is 
of great need for further exploration in this area by analyses of 
cellular immunity and pathology.
   In conclusion, the present study confirms that pp65 contributes 
to the onset and aggravation of SLE in C57BL/6 and BXSB mice, 
respectively. It is of interest that pp65 also acts as a suppressor of 
SLE-related microR-125a, microR-146a, and microR-126 in both 
strains of mice. The autoimmune effect caused by pp65 in BXSB 
mice was more potent than that in C57BL/6 mice. Thus, inhibition 
of active pp65 effects may be helpful in the treatment of SLE 
patients, and the microRNAs can potentially be applied as novel 
targets for SLE treatment.
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Comments 
Background
   The lower matrix phosphoprotein 65 (pp65), a dominant 
tegument protein of the HCMV virion, plays a significant role in 
immune evasion, and thereby controlling the innate and adaptive 
immune responses via HCMV-specific cytotoxic T lymphocytes. 
Thus, the effect of pp65 is mostly attributed to preventing infected 
cells from being destroyed. Several studies have shown that pp65 
may be associated with various autoimmune responses. 
  
Research frontiers
   This is an interesting proteomics study in tropical biomedicine. 
The work is a good information on cytomegalovirus. The standard 
animal model experiment is reported. 
Related reports
   There are some related reports but not on the same topic. The 
present work has high originality. Chang et al., has reported 
that pp65 increased the levels of ANA and anti-dsDNA antibody 
in another strain of SLE-prone mice (NZB/WFI), and the titers 
increased persistently.
Innovations and breakthroughs
   The work shows new data from protein study. The work 
has a good new data in virology, infectious medicine and 
bioinformatics. 
  
Applications
   The work can be further applied in future protein research of 
cytomegalovirus infection. The work can further applied in human 
study and can be further referenced in tropical biomedicine.    
Peer review
   The work is an interesting experimental study on proteomics 
of cytomegalovirus infection. The standard animal experimental 
study and proteomics research are done. The work produces good 
new data in virology, infectious medicine and bioinformatics. The 
work can be further referenced in tropical biomedicine.
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